S&P 500   4,592.59 (+0.56%)
DOW   34,567.82 (+0.24%)
QQQ   395.81 (+0.51%)
AAPL   169.17 (+2.34%)
MSFT   335.59 (+1.51%)
FB   317.65 (-2.10%)
GOOGL   2,877.31 (+1.39%)
AMZN   3,505.48 (-0.05%)
TSLA   1,141.57 (-0.28%)
NVDA   323.06 (-1.13%)
BABA   125.05 (-1.94%)
NIO   39.70 (+1.46%)
CGC   10.35 (-3.36%)
AMD   154.34 (-2.54%)
GE   95.35 (+0.38%)
MU   87.56 (+4.24%)
T   22.51 (-1.40%)
F   20.08 (+4.64%)
DIS   144.90 (+0.00%)
PFE   54.34 (+1.14%)
ACB   6.23 (-2.96%)
AMC   32.16 (-5.24%)
BA   194.16 (-1.87%)
S&P 500   4,592.59 (+0.56%)
DOW   34,567.82 (+0.24%)
QQQ   395.81 (+0.51%)
AAPL   169.17 (+2.34%)
MSFT   335.59 (+1.51%)
FB   317.65 (-2.10%)
GOOGL   2,877.31 (+1.39%)
AMZN   3,505.48 (-0.05%)
TSLA   1,141.57 (-0.28%)
NVDA   323.06 (-1.13%)
BABA   125.05 (-1.94%)
NIO   39.70 (+1.46%)
CGC   10.35 (-3.36%)
AMD   154.34 (-2.54%)
GE   95.35 (+0.38%)
MU   87.56 (+4.24%)
T   22.51 (-1.40%)
F   20.08 (+4.64%)
DIS   144.90 (+0.00%)
PFE   54.34 (+1.14%)
ACB   6.23 (-2.96%)
AMC   32.16 (-5.24%)
BA   194.16 (-1.87%)
S&P 500   4,592.59 (+0.56%)
DOW   34,567.82 (+0.24%)
QQQ   395.81 (+0.51%)
AAPL   169.17 (+2.34%)
MSFT   335.59 (+1.51%)
FB   317.65 (-2.10%)
GOOGL   2,877.31 (+1.39%)
AMZN   3,505.48 (-0.05%)
TSLA   1,141.57 (-0.28%)
NVDA   323.06 (-1.13%)
BABA   125.05 (-1.94%)
NIO   39.70 (+1.46%)
CGC   10.35 (-3.36%)
AMD   154.34 (-2.54%)
GE   95.35 (+0.38%)
MU   87.56 (+4.24%)
T   22.51 (-1.40%)
F   20.08 (+4.64%)
DIS   144.90 (+0.00%)
PFE   54.34 (+1.14%)
ACB   6.23 (-2.96%)
AMC   32.16 (-5.24%)
BA   194.16 (-1.87%)
S&P 500   4,592.59 (+0.56%)
DOW   34,567.82 (+0.24%)
QQQ   395.81 (+0.51%)
AAPL   169.17 (+2.34%)
MSFT   335.59 (+1.51%)
FB   317.65 (-2.10%)
GOOGL   2,877.31 (+1.39%)
AMZN   3,505.48 (-0.05%)
TSLA   1,141.57 (-0.28%)
NVDA   323.06 (-1.13%)
BABA   125.05 (-1.94%)
NIO   39.70 (+1.46%)
CGC   10.35 (-3.36%)
AMD   154.34 (-2.54%)
GE   95.35 (+0.38%)
MU   87.56 (+4.24%)
T   22.51 (-1.40%)
F   20.08 (+4.64%)
DIS   144.90 (+0.00%)
PFE   54.34 (+1.14%)
ACB   6.23 (-2.96%)
AMC   32.16 (-5.24%)
BA   194.16 (-1.87%)
NASDAQ:PPD

PPD Stock Forecast, Price & News

$47.23
+0.13 (+0.28%)
(As of 12/1/2021 01:35 PM ET)
Add
Compare
Today's Range
$47.15
$47.26
50-Day Range
$46.75
$47.41
52-Week Range
$31.54
$47.41
Volume
51,378 shs
Average Volume
1.91 million shs
Market Capitalization
$16.60 billion
P/E Ratio
47.23
Dividend Yield
N/A
Beta
1.97
30 days | 90 days | 365 days | Advanced Chart
Receive PPD News and Ratings via Email

Sign-up to receive the latest news and ratings for PPD and its competitors with MarketBeat's FREE daily newsletter.


PPD logo

About PPD

PPD, Inc., together with its subsidiaries, provides drug development services to the biopharmaceutical industry worldwide. The company operates through two segments, Clinical Development Services and Laboratory Services. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri-and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company has a collaboration with Science 37 to design, build, test, implement, and execute digital trials using Science 37's DCT SaaS-based technology platform. PPD, Inc. was founded in 1985 and is headquartered in Wilmington, North Carolina.

Headlines

PPD (NASDAQ:PPD) Reaches New 1-Year High at $47.41
November 17, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PPD
Phone
N/A
Fax
N/A
Employees
2,020
Year Founded
N/A

Sales & Book Value

Annual Sales
$4.68 billion
Cash Flow
$1.99 per share
Book Value
($1.21) per share

Profitability

Net Income
$153.69 million
Pretax Margin
7.31%

Debt

Price-To-Earnings

Miscellaneous

Free Float
344,718,000
Market Cap
$16.60 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
10/27/2021
Today
12/01/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/22/2022

MarketRank

Overall MarketRank

1.86 out of 5 stars

Medical Sector

755th out of 1,392 stocks

Commercial Physical Research Industry

10th out of 27 stocks

Analyst Opinion: 1.1Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -












PPD (NASDAQ:PPD) Frequently Asked Questions

Is PPD a buy right now?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for PPD in the last twelve months. There are currently 10 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" PPD stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PPD, but not buy additional shares or sell existing shares.
View analyst ratings for PPD
or view top-rated stocks.

How has PPD's stock price been impacted by Coronavirus?

PPD's stock was trading at $25.76 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PPD stock has increased by 83.3% and is now trading at $47.23.
View which stocks have been most impacted by COVID-19
.

When is PPD's next earnings date?

PPD is scheduled to release its next quarterly earnings announcement on Tuesday, February 22nd 2022.
View our earnings forecast for PPD
.

How were PPD's earnings last quarter?

PPD, Inc. (NASDAQ:PPD) released its earnings results on Wednesday, October, 27th. The company reported $0.43 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.38 by $0.05. The business had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.41 billion. PPD had a net margin of 6.11% and a negative trailing twelve-month return on equity of 89.48%. The company's quarterly revenue was up 26.5% compared to the same quarter last year. During the same period last year, the firm earned $0.15 earnings per share.
View PPD's earnings history
.

What price target have analysts set for PPD?

13 analysts have issued 1 year target prices for PPD's stock. Their forecasts range from $40.00 to $48.00. On average, they anticipate PPD's share price to reach $44.93 in the next twelve months. This suggests that the stock has a possible downside of 4.9%.
View analysts' price targets for PPD
or view top-rated stocks among Wall Street analysts.

Who are PPD's key executives?

PPD's management team includes the following people:
  • Mr. David S. Simmons, Chairman & CEO (Age 56, Pay $3.42M)
  • Mr. Christopher G. Scully, Exec. VP, CFO, Treasurer & Assistant Sec. (Age 50, Pay $1M)
  • Mr. William J. Sharbaugh, Chief Operating Officer (Age 58, Pay $1.12M)
  • Mr. Anshul Thakral, Exec. VP, Chief Commercial Officer & Pres of Evidera (Age 43, Pay $1.13M)
  • Dr. David Michael Johnston, Exec. VP of Global Clinical Devel. (Age 52, Pay $788.87k) (LinkedIn Profile)
  • Mr. Glen Donovan, Chief Accounting Officer (Age 47)
  • Mr. B. Judd Hartman, Exec. VP & Chief Admin. Officer (Age 57)
  • Ms. Tracy H. Krumme, VP & Head of Investor Relations (Age 53)
  • Ms. Julia James, Exec. VP, Gen. Counsel & Sec. (Age 46)
  • Mr. Ronald E. Garrow, Exec. VP & Chief HR Officer (Age 57)

What other stocks do shareholders of PPD own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PPD investors own include Cisco Systems (CSCO), Alibaba Group (BABA), Johnson & Johnson (JNJ), salesforce.com (CRM), Pfizer (PFE), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), Raytheon Technologies (RTX) and Verizon Communications (VZ).

When did PPD IPO?

(PPD) raised $1.5 billion in an initial public offering on Thursday, February 6th 2020. The company issued 60,000,000 shares at a price of $24.00-$27.00 per share. Barclays, J.P. Morgan, Morgan Stanley, Goldman Sachs, BofA Securities, Credit Suisse, Jefferies, UBS Investment Bank, Citigroup, Deutsche Bank Securities, Evercore ISI, HSBC, Mizuho Securities, Baird and William Blair acted as the underwriters for the IPO and BofA Securities, Credit Suisse, Jefferies, UBS Investment Bank, Citigroup, Deutsche Bank Securities, Evercore ISI, HSBC, Mizuho Securities, Baird, William Blair and Drexel Hamilton were co-managers.

What is PPD's stock symbol?

PPD trades on the NASDAQ under the ticker symbol "PPD."

Who are PPD's major shareholders?

PPD's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (2.49%), Goldman Sachs Group Inc. (1.69%), FIL Ltd (1.44%), Westchester Capital Management LLC (1.04%), Alpine Associates Management Inc. (1.04%) and Magnetar Financial LLC (1.02%). Company insiders that own PPD stock include Carlyle Group Management LLC, Christopher Fikry, Colin Hill, David Michael Johnston, David S Simmons, Glen Donovan, Jill Pellegrino, Karen Kaucic, Ronald E Garrow and William J Sharbaugh.
View institutional ownership trends for PPD
.

Which major investors are selling PPD stock?

PPD stock was sold by a variety of institutional investors in the last quarter, including Tudor Investment Corp Et Al, Carlson Capital L P, Millennium Management LLC, SG Americas Securities LLC, Citigroup Inc., Natixis, Samson Rock Capital LLP, and Man Group plc. Company insiders that have sold PPD company stock in the last year include David Michael Johnston, and David S Simmons.
View insider buying and selling activity for PPD
or view top insider-selling stocks.

Which major investors are buying PPD stock?

PPD stock was bought by a variety of institutional investors in the last quarter, including Balyasny Asset Management LLC, FIL Ltd, Goldman Sachs Group Inc., Soros Fund Management LLC, Deutsche Bank AG, Morgan Stanley, Omni Partners US LLC, and Bank of Nova Scotia. Company insiders that have bought PPD stock in the last two years include Christopher Fikry, David S Simmons, and William J Sharbaugh.
View insider buying and selling activity for PPD
or or view top insider-buying stocks.

How do I buy shares of PPD?

Shares of PPD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PPD's stock price today?

One share of PPD stock can currently be purchased for approximately $47.23.

How much money does PPD make?

PPD has a market capitalization of $16.60 billion and generates $4.68 billion in revenue each year. The company earns $153.69 million in net income (profit) each year or $1.00 on an earnings per share basis.

How many employees does PPD have?

PPD employs 2,020 workers across the globe.

What is PPD's official website?

The official website for PPD is www.ppdi.com.

Where are PPD's headquarters?

How can I contact PPD?

PPD's mailing address is 929 NORTH FRONT STREET, WILMINGTON NC, 28401. The company can be reached via email at [email protected].


This page was last updated on 12/1/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.